Alex Nemiroff
General Counsel at PRAXIS PRECISION MEDICINES, INC.
Net worth: 124 321 $ as of 2024-04-29
Alex Nemiroff active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | General Counsel | 2019-12-31 | - |
| Corporate Secretary | 2020-05-31 | - | |
RogCon, Inc.
 RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Founder | 2015-10-31 | - |
| Chief Executive Officer | 2015-10-31 | - | |
| Director/Board Member | 2015-10-31 | - | |
| President | 2015-10-31 | - | |
| RogCon U.R., Inc. | Chief Executive Officer | 2015-10-31 | - |
| Founder | 2015-10-31 | - |
Career history of Alex Nemiroff
Training of Alex Nemiroff
| Stephen M. Ross School of Business | Undergraduate Degree |
| Northwestern University School of Law | Graduate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Executive Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology RogCon, Inc. engages in the discovery and development of novel treatments for SCN2A mutations that cause epilepsy, autism and other neurological disorders. The company was founded by Kelley Dalby, Steven Petrou and Alex Nemiroff and is headquartered in Miami Beach, FL. | Health Technology |
| RogCon U.R., Inc. |
- Stock Market
- Insiders
- Alex Nemiroff
- Experience
